Steward Partners Investment Advisory, LLC Abb Vie Inc. Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 223,894 shares of ABBV stock, worth $43.3 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

223,894

Previous 217,544 2.92%

Holding current value

$43.3 Million

Previous $39.6 Million 3.06%

% of portfolio

0.41%

Previous 0.44%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $982,916 - $1.15 Million	6,350 Added 2.92%	223,894 $38.4 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.59 Million - $1.82 Million	9,975 Added 4.81%	217,544 $39.6 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $4.61 Million - $5.19 Million	33,489 Added 19.24%	207,569 $32.2 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $555,734 - $643,344	-4,160 Reduced 2.33%	174,080 $25.9 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $217,581 - $270,765	-1,642 Reduced 0.91%	178,240 $24 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $33,549 - $38,637	232 Added 0.13%	179,882 $28.7 Million
Q4 2022 Feb 15, 2023	SELL	$138.31 - $165.87 $170,812 - $204,849	-1,235 Reduced 0.68%	179,650 $29.1 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $334,048 - $383,131	2,489 Added 1.4%	180,885 $24.3 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $2.01 Million - $2.55 Million	-14,589 Reduced 7.56%	178,396 $27.3 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $22,040 - $27,346	-167 Reduced 0.09%	192,985 $31.3 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $688,196 - $870,767	6,406 Added 3.43%	193,152 $26.2 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $1.62 Million - $1.84 Million	15,235 Added 8.88%	186,746 $20.1 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $2.31 Million - $2.58 Million	21,997 Added 14.71%	171,511 $19.3 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $2.85 Million - $3.13 Million	27,818 Added 22.86%	149,514 $16.2 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $899,556 - $1.21 Million	11,176 Added 10.11%	121,696 $13 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $657,297 - $771,450	7,651 Added 7.44%	110,520 $9.68 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $769,064 - $1.03 Million	10,482 Added 11.35%	102,869 $10.1 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $353,331 - $535,693	5,478 Added 6.3%	92,387 $7.04 Million
Q4 2019 Jan 17, 2020	BUY	$72.13 - $90.25 $81,651 - $102,163	1,132 Added 1.32%	86,909 $7.69 Million
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $1.32 Million - $1.58 Million	-20,905 Reduced 19.6%	85,777 $6.5 Million
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $267,727 - $342,218	4,075 Added 3.97%	106,682 $7.76 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $403,673 - $475,104	5,233 Added 5.37%	102,607 $8.27 Million
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $1.32 Million - $1.63 Million	-16,964 Reduced 14.84%	97,374 $8.98 Million
Q3 2018 Oct 23, 2018	BUY	$88.91 - $98.84 $1.99 Million - $2.22 Million	22,427 Added 24.4%	114,338 $10.8 Million
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $2.69 Million - $3.19 Million	30,014 Added 48.49%	91,911 $8.52 Million
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $406,592 - $544,464	-4,419 Reduced 6.66%	61,897 $5.86 Million
Q4 2017 Jan 19, 2018	BUY	$89.56 - $98.21 $139,803 - $153,305	1,561 Added 2.41%	66,316 $6.41 Million
Q3 2017 Nov 22, 2017	BUY	$69.85 - $89.22 $219,748 - $280,686	3,146 Added 5.11%	64,755 $5.75 Million
Q2 2017 Nov 22, 2017	BUY	N/A	19,902 Added 47.72%	61,609 $4.47 Million
Q1 2017 Nov 22, 2017	BUY	N/A	22,908 Added 121.86%	41,707 $2.72 Million
Q4 2016 Nov 22, 2017	BUY	N/A	18,799	18,799 $1.18 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Abb Vie Inc. Transaction History